Table 1 Cohort descriptives
From: MRI subtypes in Parkinson’s disease across diverse populations and clustering approaches
PPMI (N = 315) | EXPANd (N = 75) | KIMOVE (N = 136) | Barcelona UB-Clínic (N = 107) | PD combined (4 cohorts N = 633) | Control group (N = 233) | |
|---|---|---|---|---|---|---|
Age, years (median, IQR) | 62.37 (14.16) | 69 (8) | 65.64 (13.56) | 65 (16) | 64.99 (13.79) | 64.5 (13.3) |
Sex (men/women) | 199/116 (63% men) | 44/31 (59% men) | 91/45 (67% men) | 67/40 (63% men) | 401/232 (63% men) | 148/85 (64% men) |
Disease duration, years (median, IQR) | 0.36 (0.53) | 4 (6) | 2 (5) | 6 (9) | 1 (3.66) | NA |
Medicated (no/yes) | 315/0 | 1/73 | 58/78 | 0/107 | 374/258 | NA |
Field Strength (1.5 T/3 T) | 100/215 | 0/75 | 93/43 | 0/107 | 193/440 | 41/192 |
Education, years (median, IQR) | 16 (4) | 15 (4) | Missing data | 10 (8) | 15 (5) | 16 (5) |
Hoehn & Yahr scale (1/1.5/2/2.5/3/4) | 135/0/178/0/2/0 | 0/0/58/0/17/0 | 33/0/56/0/19/10 | 22/5/57/12/10/0 | 190/5/349/12/48/10 | NA |
UPDRS part III (median, IQR) | 20 (12) | 31 (15) | Missing data | 13.5 (11) | 20 (13) | NA |
MoCA (median, IQR) | 28 (3) | 26 (4) | Missing data | 26 (2) | 27 (2) | 28 (2) |
